Retention of transporter activities in cryopreserved, isolated rat hepatocytes

Drug Metabolism and Disposition

Volumn 31, Issue 4, 2003, Pages 447-451

  Houle, Robert ^a,d   Raoul, Jennifer ^a,c   Lévesque, Jean François ^a   Pang, K Sandy ^b   Nicoll Griffith, Deborah A ^a   Silva, Jose M ^a  

^a Merck Ctr for Therapeutic Research   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

^d MERCK FROSST CENTRE FOR THERAPEUTIC RESEARCH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

(3,4 DIFLUOROBENZYLOXY) 5,5 DIMETHYL 4 (4 METHYLSULFONYLPHENYL)(5H) FURAN 2 ONE; 7 HYDROXY 4 (TRIFLUOROMETHYL)COUMARIN; BUFURALOL; COUMARIN DERIVATIVE; CYTOCHROME P450 2C; CYTOCHROME P450 2D; CYTOCHROME P450 3A; ESTRADIOL 17 GLUCURONIDE; ESTRONE SULFATE; FURANONE DERIVATIVE; GLUCURONOSYLTRANSFERASE; TAUROCHOLIC ACID; TOLBUTAMIDE; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

ANIMAL CELL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CRYOPRESERVATION; DRUG METABOLISM; DRUG TRANSPORT; FREEZING; INTERMETHOD COMPARISON; ISOTOPE LABELING; LIVER CELL; MALE; METHODOLOGY; MOLECULAR PROBE; NONHUMAN; PRIORITY JOURNAL; RAT; THAWING;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; BIOLOGICAL TRANSPORT; CELL SURVIVAL; CELLS, CULTURED; CRYOPRESERVATION; CYTOCHROME P-450 CYP3A; DIMETHYL SULFOXIDE; EVALUATION STUDIES; HEPATOCYTES; ISOTOPES; MALE; MONOSACCHARIDE TRANSPORT PROTEINS; OXIDOREDUCTASES, N-DEMETHYLATING; RATS; RATS, SPRAGUE-DAWLEY; STEROID HYDROXYLASES; TAUROCHOLIC ACID; TIME FACTORS; TISSUE PRESERVATION;

ANIMALIA; STAPHYLOCOCCUS PHAGE 3A;

EID: 0037378639     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.31.4.447     Document Type: Article

References (37)

1. Abu-Zahra TN, Wolkoff AW, Kim RB, and Pang KS (2000) Uptake of enalapril and expression of organic anion transporting polypeptide 1 in zonal, isolated rat hepatocytes, Drug Metab Dispos 28:801-806.
2. Akhteruzzaman S, Kato Y, Kouzuki H, Suzuki H, Hisaka A, Stieger B, Meier PJ, and Sugiyama Y (1999) Carrier-mediated hepatic uptake of peptidic endothelin antagonists in rats. J Pharmacol Exp Ther 290:1107-1115.
3. Ayrton A and Morgan P (2001) Role of transport proteins in drug absorption, distribution and excretion. Xenobiotica 31:469-497.
4. Bossuyt X, Muller B, Hagenbuch B, and Meier PJ (1996) Polyspecific steroid and drug clearance by an organic anion transporter of mammalian liver. J Pharmacol Exp Ther 276:891-896.
5. Cattori V, van Montfoort JE, Stieger B, Landmann L, Meijer DK, Winterhalter KH, Meier PJ, and Hagenbuch B (2001) Localization of organic anion transporting polypeptide 4 (Oatp4) in rat liver and comparison of its substrate specificity with Oatp1, Oatp2 and Oatp3. Pflueg Arch 443:188-195.
6. Chauret N, Tremblay N, Lackman RL, Gauthier J-Y, Silva JM, Marois J, Yergey JA, and Nicoll-Griffith DA (1999) Description of a 96-well plate assay to measure cytochrome P4503A4 inhibition in human liver microsomes using a selective fluorescent probe. Anal Biochem 276:215-226.
7. Diener B, Abdel-Latif H, Arand M, and Oesch F (1995) Xenobiotic metabolizing enzyme activities and viability are well preserved in EDTA-isolated rat liver parenchymal cells after cryopreservation. Toxicol Appl Pharmacol 130:149-153.
8. Eckhardt U, Schroéder A, Stieger B, Hochli M, Landmann L, Tynes R, Meier PJ, and Hagenbuch B (1999) Polyspecific substrate uptake by the hepatic organic anion transporter Oatp1 in stably transfected CHO cells. Am J Physiol 276:G1037-G1042.
9. Fariss MV, Brown MK, Schmitz JA, and Reed DJ (1985) Mechanism of chemical-induced toxixity: use of a rapid centrifugation technique for the separation of viable and nonviable hepatocytes. Toxicol Appl Pharmacol 79:283-295.
10. Gründemann D, Gorboulev V, Gambaryan S, Veyhl M, and Koepsell H (1994) Drug Excretion mediated by a new prototype of polyspecific transporter. Nature (Lond) 372:549-552.
11. +/bile acid transporter. J Clin Invest 93:1326-1331.
12. Hengstler JG, Utesch D, Steinberg P, Platt KL, Diener B, Ringel M, Swales N, Fischer T, Biefang K, Gerl M, Bottger T, and Oesch F (2000) Cryopreserved primary hepatocytes as a constantly available in vitro model for the evaluation of human and animal drug metabolism and enzyme induction. Drug Metab Rev 32:81-118.
13. +-independent organic anion transporter. Proc Natl Acad Sci USA 91:133-137.
14. Kato Y, Akhteruzzaman S, Hisaka A, and Sugiyama Y (1999) Hepatobiliary transport governs overall elimination of peptidic endothelin antagonists in rats. J Pharmacol Exp Ther 288: 568-574.
15. Kronbach T, Mathys D, Gut J, Catin T, and Meyers UA (1987) High-performance liquid chromatographic assays for bufuralol 1-hydroxylase, debrisoquine 4-hydroxylase and dextromethorphan O-demethylase in microsomes and purified cytochrome P-450 isozymes of human liver. Anal Biochem 162:24-32.
16. Kusuhara H and Sugiyama Y (2002) Drug-drug interactions involving the membrane transport process, in Drug-Drug Interactions (Rodrigues, DA ed) chapter 5, pp 123-188, Marcel Dekker, New York, NY.
17. Li AP, Lu C, Brent JA, Pham C, Fackett A, Ruegg CE, and Sliver PM (1999) Cryopreserved human hepatocytes: characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability and drug-drug interaction potential. Chem-Biol Interact 121:17-35.
18. Liang D, Hagenbuch B, Stieger B, and Meier PJ (1993) Parallel decrease of Na(+)-taurocholate cotransport and its encoding mRNA in primary cultures of rat hepatocytes. Hepatology 18:1162-1166.
19. Liu X, Brower KL, Gan L, Brower KR, Stieger B, Meier P, Andus K, and LeCluyse E (1998) Partial maintenance of taurocholate uptake by adult rat hepatocytes cultured in a sandwich configuration. Pharm Res (NY) 15:1533-1539.
20. Liu X, LeCluyse E, Brower KL, Gan L, Lemasters J, Stieger B, Meier P, and Brower KR (1999) Biliary excretion in primary rat hepatocytes cultured in a collagen-sandwich configuration. Am J Physiol 277:G12-G21.
21. Madan A, Dehaan R, Mudra D, Carroll K, Lecluyse E, and Parkinson A (1999) Effect of cryopreservation on cytochrome P-450 enzyme induction in cultured rat hepatocytes, Drug Metab Dispos 27:327-335.
22. Meijer DKF, Mol WEM, Müller M, and Kurz G (1990) Carrier-mediated transport in the hepatic distribution and elimination of drugs with special reference to the category of organic cations. J Pharmacokinet Biopharm 18:35-70.
23. Meijer DKF, Smit JW, and Müller M (1997) Hepatobiliary elimination of cationic drugs: the role of P-glycoproteins and other ATP-dependant transporters. Adv Drug Delivery Rev 25:159- 200.
24. Meng LJ, Wang P, Wolkoff AW, Kim RB, Tirona RG, Hofmann AF, and Pang KS (2002) Transport of the sulfated, amidated bile acid, sulfolithocholyltaurine, into rat hepatocytes is mediated by Oatp1 and Oatp2, Hepatology 35:1031-1040.
25. Miners JO, Smith KJ, Robson RA, McManus ME, Veronese ME, and Birkett DJ (1988) Tolbutamide hydroxylation by human liver microsomes. Biochem Pharmacol 37:1137-1144.
26. Moldéus P, Hogberg J, and Orrenius S (1978) Isolation and use of liver cells, Methods Enzymol 52:60-71.
27. Olinga P, Merema M, Hof IH, Slooff MJ, Proost JH, Meijer DK, and Groothuis GM (1998a) Characterization of the uptake of rocuronium and digoxin in human hepatocytes: carrier specificity and comparison with in vivo data. J Pharmacol Exp Ther 285:506-510.
28. Olinga P, Merema M, Sandker GW, Slooff MJ, Meijer DK, and Groothuis GM (1998b) Uptake of taurocholic acid in human hepatocytes isolated from livers of donors of different age. J Pediatr Gastroenterol Nutr 27:366-368.
29. Payen L, Courtois A, Campion J-P, Guillouzo A, and Fardel O (2000) Characterization and inhibition by a wide range of xenobiotics of organic anion excretion by primary human hepatocytes. Biochem Pharmacol 60:1967-1975.
30. Roelofsen H, Bakker CT, Schoemaker B, Heijn M, Jansen PL, and Elferink RP (1995) Redistribution of canalicular organic anion transport activity in isolated and cultured rat hepatocytes. Hepatology 21:1649-1657.
31. Sandker GW, weet B, Olinga P, Wolters H, Sloof MJ, Meijer DK and Groothuis GM (1994) Characterisation of transport in isolated human hepatocytes. A study with the bile acid taurocholic acid, the uncharged ouabain and the organic cations vecuronium and rocuronium. Biochem Pharmacol 47:2193-2200.
32. Silva JM, Day SH, and Nicoll-Griffith DA (1999) Induction of cytochrome-P450 in cryopreserved rat and human hepatocytes. Chem-Biol Interact 121:49-63.
33. Steinberg P, Fischer T, Kiulies S, Biefang K, Platt K-L, Oesch F, Bottger T, Bulitta C, Kempf P, and Hengstler J (1999) Drug metabolizing capacity of cryopreserved human, rat and mouse liver parenchymal cells in suspension. Drug Metab Dispos 27:1415-1422.
34. Sugiyama D, Kusuhara H, Shitara Y, Abe T, and Sugiyama Y (2002) Effect of 17 beta-estradiol-D-17 beta-glucuronide on the rat organic anion transporting polypeptide 2-mediated transport differs depending on substrates. Drug Metab Dispos 30:220-223.
35. Tan E, Tirona RG, and Pang KS (1999) Lack of zonal uptake of estrone sulfate in enriched periportal and perivenous isolated rat hepatocytes. Drug Metab Dispos 27:336-341.
36. Zaleski J, Richburg J, and Kauffman F (1993) Preservation of the rate and profile of xenobiotic metabolism in rat hepatocytes stored in liquid nitrogen. Biochem Pharmacol 46:111-116.
37. Zhou X, Placidi M, and Rahmani R (1994) Uptake and metabolism of vinca alkaloids by freshly isolated human hepatocytes in suspension. Anticancer Res 14:1017-1022.